sr141716 has been researched along with scopolamine hydrobromide in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Lichtman, AH; Martin, BR | 1 |
Lafon, N; Le Fur, G; Péŕio, A; Rinaldi-Carmona, M; Soubrié, P; Storme, JJ; Terranova, JP | 1 |
Moerschbaecher, JM; Nakamura-Palacios, EM; Winsauer, PJ | 1 |
Egashira, N; Fujii, M; Fujiwara, M; Hirosawa, N; Iwasaki, K; Matsumoto, Y; Mishima, K | 1 |
Fernandes, MS; Pamplona, FA; Takahashi, RN | 1 |
Bura, SA; Castañé, A; Ledent, C; Maldonado, R; Valverde, O | 1 |
Goonawardena, AV; Hampson, RE; Pertwee, R; Platt, B; Riedel, G; Robinson, L | 1 |
8 other study(ies) available for sr141716 and scopolamine hydrobromide
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism.
Topics: Animals; Dronabinol; Male; Maze Learning; Memory; Physostigmine; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Scopolamine | 1996 |
Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716.
Topics: Age Factors; Animals; Dose-Response Relationship, Drug; Male; Memory; Mice; Piperidines; Pyrazoles; Rats; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Scopolamine | 1996 |
Effects of the cannabinoid ligand SR 141716A alone or in combination with delta9-tetrahydrocannabinol or scopolamine on learning in squirrel monkeys.
Topics: Animals; Dose-Response Relationship, Drug; Dronabinol; Female; Hallucinogens; Learning; Ligands; Muscarinic Antagonists; Piperidines; Pyrazoles; Rimonabant; Saimiri; Scopolamine | 2000 |
Characteristics of learning and memory impairment induced by delta9-tetrahydrocannabinol in rats.
Topics: Animals; Avoidance Learning; Discrimination Learning; Dronabinol; Hallucinogens; Injections, Intraventricular; Learning Disabilities; Maze Learning; Memory Disorders; Memory, Short-Term; Muscarinic Agonists; Muscarinic Antagonists; Pilocarpine; Piperidines; Pyrazoles; Rats; Rimonabant; Scopolamine | 2001 |
The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze.
Topics: Animals; Anxiety; Cannabinoid Receptor Modulators; Drug Interactions; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Mice; Motor Activity; Muscarinic Antagonists; Neural Pathways; Neurons; Nootropic Agents; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Scopolamine | 2005 |
Genetic and pharmacological approaches to evaluate the interaction between the cannabinoid and cholinergic systems in cognitive processes.
Topics: Animals; Avoidance Learning; Cognition; Male; Mice; Mice, Knockout; Nicotine; Physostigmine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Nicotinic; Rimonabant; Scopolamine | 2007 |
WIN55,212-2 induced deficits in spatial learning are mediated by cholinergic hypofunction.
Topics: Acetylcholine; Animals; Benzoxazines; Cannabinoid Receptor Agonists; Cholinergic Antagonists; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Learning Disabilities; Male; Maze Learning; Memory; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Rats; Rimonabant; Scopolamine; Spatial Behavior | 2010 |